نتایج جستجو برای: hepatitis monthly
تعداد نتایج: 159413 فیلتر نتایج به سال:
background citation analysis as one of the most widely used methods of bibliometrics can be used for computing the various impact measures for scholars based on data from citation databases. journal citation reports (jcr) from thomson reuters provides annual report in the form of impact factor (if) for each journal. objectives we aimed to evaluate the citation parameters of hepatitis monthly by...
BACKGROUND There is no standard management of reactivation of hepatitis B virus (HBV) infection in HBV-resolved patients without hepatitis B surface antigen (HBsAg), but with antibodies against hepatitis B core antigen and/or antibodies against HBsAg (anti-HBs). METHODS We conducted a prospective observational study to evaluate the occurrence of HBV reactivation by serial monthly monitoring o...
BACKGROUND The standard treatment for HCV infection involves combination therapy with pegylated interferon and ribavirin. The study was conducted to determine the effect of standard interferon and ribavirin on the haemoglobin level in patients treated for hepatitis-C. METHODS PCR confirmed 58 patients of chronic hepatitis-C treated with standard interferon and ribavirin for six months were in...
Background. Hepatitis C virus (HCV) represents a major worldwide public health problem. Though several studies from Yemen have provided an estimate of the prevalence of this viral infection, there exist only few studies which reflect the status in the general population. Aim. The present study was designed to investigate the prevalence of hepatitis C infection among general population in centra...
The current study aims to investigate the hepatoprotective effects of LivPro® among hepatitis C patients. An interventional was performed n=89 duration 3 months and assessment for liver function, ELISA, Viral load monthly patients recruited in this study. Mean difference measured at a Confidence Interval (CI 95%) p-value less than 0.05 considered statistically significant. This stu
The combination therapy with hepatitis B immunoglobulin (HBIG) and nucleoside analogue is well tolerated for the hepatitis B recipients after liver transplantation, but its cost is an important problem in these days. Here we report the efficacy of nucleoside analogue therapy following one-year course of HBIG plus nucleoside analogue after living donor liver transplantation (LDLT). Out of 103 LD...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید